Health committee  I'll start, and Mehmood can complement. We work with the health care system in many different ways. We work with patients and with many stakeholders in health care, and of course everyone has been committed to improving the situation, including us. We mentioned in our opening st

Health committee  Basically, we don't agree.

Health committee  We're convinced it would have a negative impact. It's currently under negotiation with the provinces. That's the way the process is going. Significant discounts are being given. We firmly believe that these new regulations go beyond provincial jurisdiction. It's important to tak

Health committee  Our concern is that we will not be able to bring life-saving drugs to Canadian patients.

Health committee  I think the issue here is.... We've spoken about organizational mandates and our values and we are a company deeply focused on patient needs. We're here to represent the fact that the issue with the regulations is that the original intent of the PMPRB was to prevent abuse of pate

Health committee  Let me take you through the process—

Health committee  This will get to what you're referring to. I think it's really important to understand that the original intent of the PMPRB was to prevent abuse of excessive prices, and what's happening here goes well beyond this. Our concern is that the guidelines create a great deal of uncer

Health committee  Yes, and they are significant.

Health committee  Those rebates are confidential based on negotiations with the province.

Health committee  Those are in Canada.

Health committee  You're asking about the impact we expect PMPRB to have on us. The first thing to understand is that we see a great deal of lack of clarity and uncertainty with the PMPRB process so far. We've conducted an assessment of the impact on our existing and upcoming products. We've actu

Health committee  Yes, I'll take that question. Thank you for asking. The public prices of drugs in Canada are in line with countries that have similar GDPs and health care structures. Further to this, it's important to understand that there are significant rebates that are provided to provinci

Health committee  Would you like me to continue?

Health committee  Our vision is value through innovation. Simply put, this means we want to find new and better ways of improving health, and we provide value by being innovative. We are committed to the development of innovative, cost-saving medications that fulfill unmet medical needs. Through

Health committee  Good afternoon. My name is Annie Beauchemin, and I'm with Boehringer Ingelheim. I am joined by my colleague, Mehmood Alibhai. Thank you, Mr. Chair and honourable members of the Standing Committee on Health, for the opportunity and for inviting us to provide testimony today. We